Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

被引:374
作者
Husereau, Don [1 ,2 ]
Drummond, Michael [3 ]
Augustovski, Federico [4 ,5 ]
De Bekker-Grob, Esther [10 ]
Briggs, Andrew H. [6 ]
Carswell, Chris [7 ]
Caulley, Lisa [8 ]
Chaiyakunapruk, Nathorn [9 ]
Greenberg, Dan [11 ]
Loder, Elizabeth [12 ]
Mauskopf, Josephine [13 ]
Mullins, C. Daniel [14 ]
Petrou, Stavros [15 ]
Pwu, Raoh-Fang [16 ]
Staniszewska, Sophie [17 ]
机构
[1] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
[2] Inst Hlth Econ, Edmonton, AB, Canada
[3] Univ York, Ctr Hlth Econ, York, N Yorkshire, England
[4] Inst Clin Effectiveness & Hlth Policy, Hlth Technol Assessment & Hlth Econ, Buenos Aires, DF, Argentina
[5] Natl Sci & Tech Res Council Buenos Aires, Buenos Aires, DF, Argentina
[6] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London, England
[7] Springer Nat, Auckland, New Zealand
[8] Ottawa Hosp, Ottawa, ON, Canada
[9] Univ Utah, Dept Pharmacotherapy, Salt Lake City, UT USA
[10] Erasmus Univ, Sch Hlth Policy & Management, Rotterdam, Netherlands
[11] Ben Gurion Univ Negev, Dept Hlth Syst Management, Beer Sheva, Israel
[12] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[13] RTI Int, Res Triangle Pk, NC USA
[14] Univ Maryland, Pharmaceut Hlth Serv Res Dept, Baltimore, MD USA
[15] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxon, England
[16] Taiwan Minist Hlth & Welf, Taipei, Taiwan
[17] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England
关键词
COST-EFFECTIVENESS ANALYSIS; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; DESIGN;
D O I
10.1016/j.jval.2021.11.1351
中图分类号
F [经济];
学科分类号
02 ;
摘要
Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 45 条
  • [41] Under-reporting of Validation Efforts for Health Economic Models Persists Despite the Availability of Validation Tools: A Systematic Review
    Abraham, Katharina
    Ramos, Isaac Corro
    Braal, C. Louwrens
    Feenstra, Talitha
    Kleijburg, Anne
    van Voorn, George A. K.
    Uyl-de Groot, Carin
    PHARMACOECONOMICS, 2025,
  • [42] Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022-2031
    Abushanab, Dina
    Marquina, Clara
    Morton, Jedidiah I.
    Al-Badriyeh, Daoud
    Lloyd, Melanie
    Magliano, Dianna J.
    Liew, Danny
    Ademi, Zanfina
    PHARMACOECONOMICS, 2023, 41 (06) : 719 - 732
  • [43] Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer
    de Boer, Pieter T.
    Frederix, Geert W. J.
    Feenstra, Talitha L.
    Vemer, Pepijn
    PHARMACOECONOMICS, 2016, 34 (09) : 833 - 845
  • [44] Evaluation of health and economic effects of United States school meal standards consistent with the 2020-2025 dietary guidelines for Americans
    Wang, Lu
    Cohen, Juliana F. W.
    Maroney, Meghan
    Cudhea, Fredrick
    Hill, Alla
    Schwartz, Colin
    Lurie, Peter
    Mozaffarian, Dariush
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2023, 118 (03) : 605 - 613
  • [45] Economic Empowerment, HIV Risk Behavior, and Mental Health Among School-Going Adolescent Girls in Uganda: Longitudinal Cluster- Randomized Controlled Trial, 2017-2022
    Ssewamala, Fred M.
    Brathwaite, Rachel
    Neilands, Torsten B.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2023, 113 (03) : 306 - 315